Shopping Cart 0
Cart Subtotal
USD 0

Aceto Corp (ACET)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Aceto Corp (Aceto) carries out the marketing, selling and distribution of pharmaceutical intermediates, human health products and performance chemical products. The company's product portfolio includes finished dosage form generic pharmaceuticals, pharmaceutical active ingredients and intermediates, nutraceutical products, specialty performance chemicals including agricultural protection products and agricultural intermediates. It distributes several chemical compounds used primarily as finished products or raw materials in the agricultural, pharmaceutical, nutraceutical, coatings and industrial chemical industries. The company operates subsidiaries in the US, Germany, Luxembourg, China, the Netherlands, France, France, Hong Kong, Singapore, India, the UK and Philippines. Aceto is headquartered in Port Washington, New York, the US.

Aceto Corp (ACET)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Aceto Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Aceto Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Aceto Corp, Pharmaceuticals & Healthcare, Deal Details 10

Asset Purchase 10

Rising Pharma Acquires Generic Products and Related Assets of Citron Pharma and Lucid Pharma for USD429 Million 10

Rising Pharma to Acquire Three ANDAs from Endo International 11

Rising Pharma Acquires Three Opthalmic ANDA's from Nexus Pharma 12

Rising Pharma Acquires Doxercalciferol, Paricalcitol and Dutasteride from Par Pharma 13

Aceto Acquires Certain Assets From Rising Pharma 14

Partnerships 15

Panacea Biotec Enters into Agreement with Rising Pharma 15

Rising Pharma Enters Into Co-Marketing Agreement With Covis Pharma For Parnate 16

Debt Offering 17

Aceto Completes Underwriters' Exercise of Over-Allotment Option of 2% Notes Due 2020 for USD18.7 Million 17

Asset Transactions 18

Aceto Acquires Certain Assets From Rising Pharma 18

Acquisition 19

Aceto Completes Acquisition Of Pack Pharma For US$100 Million 19

Aceto Corp-Key Competitors 21

Key Employees 22

Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Financial Announcements 25

Nov 02, 2016: ACETO Reports Fiscal 2017 First Quarter Results 25

Aug 25, 2016: ACETO Reports Fiscal 2016 Fourth Quarter and Record Full Year Results 27

Feb 04, 2016: ACETO Reports Fiscal 2016 Second Quarter Results 30

Corporate Communications 32

Feb 02, 2017: ACETO Appoints Vimal Kavuru to the Board of Directors 32

Sep 06, 2016: ACETO Appoints William C. Kennally, III to the Board of Directors 33

Jul 18, 2016: ACETO Names Walter Kaczmarek III Chief Operating Officer 34

Government and Public Interest 35

Dec 15, 2016: ACETO Comments on Legal Proceedings affecting the Generic Pharmaceuticals Industry 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Aceto Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Aceto Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

Aceto Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Aceto Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Aceto Corp, Deals By Therapy Area, 2011 to YTD 2017 8

Aceto Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Rising Pharma Acquires Generic Products and Related Assets of Citron Pharma and Lucid Pharma for USD429 Million 10

Rising Pharma to Acquire Three ANDAs from Endo International 11

Rising Pharma Acquires Three Opthalmic ANDA's from Nexus Pharma 12

Rising Pharma Acquires Doxercalciferol, Paricalcitol and Dutasteride from Par Pharma 13

Aceto Acquires Certain Assets From Rising Pharma 14

Panacea Biotec Enters into Agreement with Rising Pharma 15

Rising Pharma Enters Into Co-Marketing Agreement With Covis Pharma For Parnate 16

Aceto Completes Underwriters' Exercise of Over-Allotment Option of 2% Notes Due 2020 for USD18.7 Million 17

Aceto Acquires Certain Assets From Rising Pharma 18

Aceto Completes Acquisition Of Pack Pharma For US$100 Million 19

Aceto Corp, Key Competitors 21

Aceto Corp, Key Employees 22

Aceto Corp, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Aceto Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Aceto Corp (Aceto) carries out the marketing, selling and distribution of pharmaceutical intermediates, human health products and performance chemical products. The company's product portfolio includes finished dosage form generic pharmaceuticals, pharmaceutical active ingredients and intermediates, nutraceutical products, specialty performance chemicals including agricultural protection products and agricultural intermediates. It distributes several chemical compounds used primarily as finished products or raw materials in the agricultural, pharmaceutical, nutraceutical, coatings and industrial chemical industries. The company operates subsidiaries in the US, Germany, Luxembourg, China, the Netherlands, France, France, Hong Kong, Singapore, India, the UK and Philippines. Aceto is headquartered in Port Washington, New York, the US.

Aceto Corp (ACET)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Aceto Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Aceto Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Aceto Corp, Pharmaceuticals & Healthcare, Deal Details 10

Asset Purchase 10

Rising Pharma Acquires Generic Products and Related Assets of Citron Pharma and Lucid Pharma for USD429 Million 10

Rising Pharma to Acquire Three ANDAs from Endo International 11

Rising Pharma Acquires Three Opthalmic ANDA's from Nexus Pharma 12

Rising Pharma Acquires Doxercalciferol, Paricalcitol and Dutasteride from Par Pharma 13

Aceto Acquires Certain Assets From Rising Pharma 14

Partnerships 15

Panacea Biotec Enters into Agreement with Rising Pharma 15

Rising Pharma Enters Into Co-Marketing Agreement With Covis Pharma For Parnate 16

Debt Offering 17

Aceto Completes Underwriters' Exercise of Over-Allotment Option of 2% Notes Due 2020 for USD18.7 Million 17

Asset Transactions 18

Aceto Acquires Certain Assets From Rising Pharma 18

Acquisition 19

Aceto Completes Acquisition Of Pack Pharma For US$100 Million 19

Aceto Corp-Key Competitors 21

Key Employees 22

Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Financial Announcements 25

Nov 02, 2016: ACETO Reports Fiscal 2017 First Quarter Results 25

Aug 25, 2016: ACETO Reports Fiscal 2016 Fourth Quarter and Record Full Year Results 27

Feb 04, 2016: ACETO Reports Fiscal 2016 Second Quarter Results 30

Corporate Communications 32

Feb 02, 2017: ACETO Appoints Vimal Kavuru to the Board of Directors 32

Sep 06, 2016: ACETO Appoints William C. Kennally, III to the Board of Directors 33

Jul 18, 2016: ACETO Names Walter Kaczmarek III Chief Operating Officer 34

Government and Public Interest 35

Dec 15, 2016: ACETO Comments on Legal Proceedings affecting the Generic Pharmaceuticals Industry 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Aceto Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Aceto Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

Aceto Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Aceto Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Aceto Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Aceto Corp, Deals By Therapy Area, 2011 to YTD 2017 8

Aceto Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Rising Pharma Acquires Generic Products and Related Assets of Citron Pharma and Lucid Pharma for USD429 Million 10

Rising Pharma to Acquire Three ANDAs from Endo International 11

Rising Pharma Acquires Three Opthalmic ANDA's from Nexus Pharma 12

Rising Pharma Acquires Doxercalciferol, Paricalcitol and Dutasteride from Par Pharma 13

Aceto Acquires Certain Assets From Rising Pharma 14

Panacea Biotec Enters into Agreement with Rising Pharma 15

Rising Pharma Enters Into Co-Marketing Agreement With Covis Pharma For Parnate 16

Aceto Completes Underwriters' Exercise of Over-Allotment Option of 2% Notes Due 2020 for USD18.7 Million 17

Aceto Acquires Certain Assets From Rising Pharma 18

Aceto Completes Acquisition Of Pack Pharma For US$100 Million 19

Aceto Corp, Key Competitors 21

Aceto Corp, Key Employees 22

Aceto Corp, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Aceto Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.